
Jagsonpal Pharmaceuticals Investor Relations Material
Latest events

Q1 25/26
Jagsonpal Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Jagsonpal Pharmaceuticals Limited
Access all reports
Jagsonpal Pharmaceuticals Limited is a pharmaceutical company engaged in the development, manufacturing, and marketing of branded generic formulations. The company offers a range of dosage forms including tablets, capsules, syrups, and injectables across therapeutic segments such as gynecology, orthopedics, dermatology, and general medicine. It serves domestic and international markets through an established distribution network and field force. The company is headquartered in New Delhi, India, and its shares are listed on the BSE.
Key slides for Jagsonpal Pharmaceuticals Limited


Q4 24/25
Jagsonpal Pharmaceuticals Limited


Q1 25/26
Jagsonpal Pharmaceuticals Limited
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
JAGSNPHARM
Country
🇮🇳 India